|
2020 Journal Article A retrospective review examining intravenous iron infusion dosing methodsWinckel, Karl, Sullivan, Sara, Vongphakdi, Mitt and Snoswell, Centaine L. (2020). A retrospective review examining intravenous iron infusion dosing methods. Journal of Pharmacy Practice and Research, 51 (3) jppr.1698, 225-230. doi: 10.1002/jppr.1698 |
|
2020 Journal Article Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalinWinckel, Karl, Daglish, Mark, Pache, David and Hollingworth, Samantha A. (2020). Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin. Australian Health Review, 45 (2), 261-262. doi: 10.1071/ah20060 |
|
2020 Journal Article Unfractionated heparin dosing in obese patientsGeorge, Christopher, Barras, Michael, Coombes, Judith and Winckel, Karl (2020). Unfractionated heparin dosing in obese patients. International Journal of Clinical Pharmacy, 42 (2), 462-473. doi: 10.1007/s11096-020-01004-5 |
|
2020 Journal Article Comment on: “Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study”van Oosterom, Nameer, Winckel, Karl and Barras, Michael (2020). Comment on: “Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study”. Clinical Drug Investigation, 40 (3), 287-288. doi: 10.1007/s40261-020-00889-4 |
|
2019 Journal Article Strategies to counter antipsychotic-associated weight gain in patients with schizophreniaMarteene, Wade, Winckel, Karl, Hollingworth, Sam, Kisely, Steve, Gallagher, Erin, Hahn, Margaret, Ebdrup, Bjørn H, Firth, Joseph and Siskind, Dan (2019). Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opinion on Drug Safety, 18 (12), 1-12. doi: 10.1080/14740338.2019.1674809 |
|
2019 Journal Article Ivabradine in patients with left-ventricular dysfunction and coronary artery diseasePham, Betty, Winckel, Karl and Snoswell, Centaine L. (2019). Ivabradine in patients with left-ventricular dysfunction and coronary artery disease. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (2), 131-132. |
|
2019 Journal Article Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesityvan Oosterom, Nameer, Winckel, Karl and Barras, Michael (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Journal of Thrombosis and Thrombolysis, 48 (3), 387-393. doi: 10.1007/s11239-019-01847-4 |
|
2019 Journal Article An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophreniaMcArdle, P. A., De Mel, V., DeMonte, V., Winckel, K., Gore-Jones, V., Foley, S., Korman, N., Parker, S., Dark, F. and Siskind, D. (2019). An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia. Schizophrenia Research, 206, 450-451. doi: 10.1016/j.schres.2018.11.030 |
|
2019 Journal Article Primary and secondary prevention of strokeBarras, M.A. and Winckel, K. (2019). Primary and secondary prevention of stroke. Australian Pharmacist, 12, 42-51. |
|
2018 Journal Article Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018). Psychopharmacology, 235 (7), 2193-2193. doi: 10.1007/s00213-018-4909-5 |
|
2018 Journal Article Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Psychopharmacology, 235 (7), 1915-1921. doi: 10.1007/s00213-018-4881-0 |
|
2018 Journal Article CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapineSiskind, Dan, Friend, Nadia, Russell, Anthony, McGrath, John J., Lim, Carmen, Patterson, Sue, Flaws, Dylan, Stedman, Terry, Moudgil, Vikas, Sardinha, Savio, Suetani, Shuichi, Kisely, Steve, Winckel, Karl and Baker, Andrea (2018). CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. BMJ Open, 8 (3) e021000, e021000. doi: 10.1136/bmjopen-2017-021000 |
|
2017 Journal Article Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)Siskind, Dan J., Russell, Anthony W., Gamble, Clare, Winckel, Karl, Mayfield, Karla, Hollingworth, Sam, Hickman, Ingrid, Siskind, Victor and Kisely, Steve (2017). Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX). Diabetes, obesity & metabolism, 20 (4), 1050-1055. doi: 10.1111/dom.13167 |
|
2017 Journal Article Clozapine in primary careWinckel, Karl and Siskind, Dan (2017). Clozapine in primary care. Australian Prescriber, 40 (6), 231-236. doi: 10.18773/austprescr.2017.067 |
|
2017 Journal Article Utilisation of nicotine replacement therapy within hospital pharmacist initiated smoking-cessation intervention - a pragmatic randomised controlled trialGupta, D., Winckel, K., Burrows, J., Ross, J. and Upham, J. W. (2017). Utilisation of nicotine replacement therapy within hospital pharmacist initiated smoking-cessation intervention - a pragmatic randomised controlled trial. Journal of Smoking Cessation, 12 (1), 1-10. doi: 10.1017/jsc.2015.14 |
|
2017 Journal Article The impact of clozapine on hospital use: a systematic review and meta-analysisLand, R., Siskind, D., McArdle, P., Kisely, S., Winckel, K. and Hollingworth, S. A. (2017). The impact of clozapine on hospital use: a systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 135 (4), 296-309. doi: 10.1111/acps.12700 |
|
2016 Journal Article An evaluation of the utilisation of the Medication Action Plan form in a tertiary hospital: what is the impact of the pharmacist?Shafiee Hanjani, Leila, Apostolidis, Anastasia, Winckel, Karl and Burrows, Judith A. (2016). An evaluation of the utilisation of the Medication Action Plan form in a tertiary hospital: what is the impact of the pharmacist?. Journal of Pharmacy Practice and Research, 47 (4), 257-262. doi: 10.1002/jppr.1237 |
|
2016 Journal Article An argument to continue statins for secondary prevention in the elderlyWinckel, Karl (2016). An argument to continue statins for secondary prevention in the elderly. Australian Pharmacist, 35 (6), 66-67. |
|
2016 Journal Article Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetesMayfield, Karla, Siskind, Dan, Winckel, Karl, Russell, Anthony W., Kisely, Steve, Smith, Greg and Hollingworth, Samantha (2016). Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes. Journal of Psychopharmacology, 30 (3), 227-236. doi: 10.1177/0269881115625496 |
|
2015 Journal Article Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013Forrester, T., Siskind, D., Winckel, K., Wheeler, A. and Hollingworth, S. (2015). Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013. Pharmacopsychiatry, 48 (4-5), 164-169. doi: 10.1055/s-0035-1554713 |
